<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang X</submitter><funding>Shanghai Science and Technology Committee</funding><funding>National Natural Science Foundation of China</funding><pagination>11281-11295</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9208480</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(4)</volume><pubmed_abstract>As a novel noncoding RNA cluster, miR-17-92 cluster include six members: miR-17, miR-18a, miR-19a, miR-19b-1, miR-20a, and miR-92a. Dysregulation of miR-17-92 has been proved to be connected with the advancement of a series of human diseases, but the roles of miR-17-92 cluster in non-small cell lung cancer (NSCLC) have not been absolutely elaborated. Herein, we determined that miR-17-92 cluster were upregulated significantly in NSCLC tissues, and the cell proliferation, migration and cycle progression of NSCLC were also facilitated under the function of miR-17-92 cluster. &lt;i>Sprouty 4&lt;/i> (&lt;i>SPRY4&lt;/i>) was a direct target of miR-92a, and its overexpression restrained the exacerbation of NSCLC induced by miR-92a. Furthermore, the tumor xenograft assay showed that miR-92a facilitated tumor </pubmed_abstract><journal>Bioengineered</journal><pubmed_title>Downregulated miR-18a and miR-92a synergistically suppress non-small cell lung cancer via targeting &lt;i>Sprouty 4&lt;/i>.</pubmed_title><pmcid>PMC9208480</pmcid><funding_grant_id>20S11901300</funding_grant_id><funding_grant_id>81572122</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Zou H</pubmed_authors><pubmed_authors>Wu Z</pubmed_authors><pubmed_authors>Hua Z</pubmed_authors><pubmed_authors>Chai B</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Ma Z</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wang X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Downregulated miR-18a and miR-92a synergistically suppress non-small cell lung cancer via targeting &lt;i>Sprouty 4&lt;/i>.</name><description>As a novel noncoding RNA cluster, miR-17-92 cluster include six members: miR-17, miR-18a, miR-19a, miR-19b-1, miR-20a, and miR-92a. Dysregulation of miR-17-92 has been proved to be connected with the advancement of a series of human diseases, but the roles of miR-17-92 cluster in non-small cell lung cancer (NSCLC) have not been absolutely elaborated. Herein, we determined that miR-17-92 cluster were upregulated significantly in NSCLC tissues, and the cell proliferation, migration and cycle progression of NSCLC were also facilitated under the function of miR-17-92 cluster. &lt;i>Sprouty 4&lt;/i> (&lt;i>SPRY4&lt;/i>) was a direct target of miR-92a, and its overexpression restrained the exacerbation of NSCLC induced by miR-92a. Furthermore, the tumor xenograft assay showed that miR-92a facilitated tumor </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-05T16:14:30.658Z</modification><creation>2025-04-05T16:14:30.658Z</creation></dates><accession>S-EPMC9208480</accession><cross_references><pubmed>35484993</pubmed><doi>10.1080/21655979.2022.2066755</doi></cross_references></HashMap>